Medtronic Vascular

What Medtronic Vascular does

Medtronic Vascular is a business unit of Medtronic plc (NYSE: MDT), a global medical technology company headquartered in Dublin, Ireland with operational headquarters in Minneapolis, Minnesota. The division designs, develops, and commercializes vascular medical devices spanning coronary, peripheral, renal, and neurovascular indications. Its core product portfolio includes stents, stent delivery systems, vascular snares, and catheters, with additional neurovascular capability acquired through MindFrame. The division primarily serves hospitals and healthcare systems, with the customer value proposition centered on timely stroke diagnosis and treatment, minimally invasive vascular procedures, and integrated stroke care systems.

The division operates within a parent-company structure that provides global sales, clinical, regulatory, and service infrastructure. Its go-to-market is hospital-channel-driven, selling capital and consumable devices into vascular and neurovascular care pathways; specific pricing is not publicly disclosed for the division. Notable strategic activity includes a 2024-10-24 strategic advocacy partnership with Royal Philips focused on stroke awareness, stroke-ready hospital expansion, and integrated imaging-plus-device stroke care systems (with both companies joining the World Stroke Organization Advocacy Coalition). A catheter-related patent infringement dispute with Teleflex was settled; terms were not disclosed. The division employs 501-1,000 people per the source data, and was founded in 1991.

Customer segments concentrate in hospitals and healthcare systems addressing stroke diagnosis and treatment and minimally invasive vascular procedures. Differentiation rests on domain specialization in catheter and neurovascular stroke-treatment devices, acquired IP from MindFrame, and the parent company's integrated cardiovascular portfolio scale. Marketing channels for the division specifically are not detailed in available sources beyond industry partnerships and advocacy programs.

Name

Medtronic Vascular

Legal name

Medtronic plc

Website

https://medtroniccvg.com

Company type

Public

Founded year

1991

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Medtronic Vascular is a division of Medtronic plc that develops vascular medical devices, including stents, catheters, and neurovascular stroke-treatment devices, for hospitals and healthcare systems treating coronary, peripheral, renal, and neurovascular conditions.

Ownership category

akta.pro rank

Product category

Vascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Coronary Stents & Drug-Eluting Technologies (HLAHAFAA)

akta.pro secondary industries

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)

Keywords

• Vascular medical devices
• Neurovascular devices
• Catheter technology
• Stroke treatment devices
• Coronary stents

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Marketing channels1 record

Core offering

Medtronic Vascular designs, develops, and commercializes catheter-based medical devices for vascular interventions across coronary, peripheral, and neurovascular indications. Its portfolio includes stents, stent delivery systems, vascular snares, and catheters used in minimally invasive vascular procedures, as well as specialized neurovascular devices for stroke diagnosis and treatment.

Product overview

Medtronic Vascular operates as a division of Medtronic, a global leader in medical technology. The company develops and commercializes vascular medical devices including stents, stent delivery systems, vascular snares, and catheters for the treatment of cardiovascular and neurovascular conditions. The product portfolio encompasses technologies for peripheral vascular interventions, renal artery stenting, and stroke treatment. Based on the available source data, specific product names and detailed descriptions for individual products/modules were not directly captured, as the sources primarily reference general market analyses and industry trends rather than Medtronic Vascular's proprietary product catalog.

Differentiator

Problem solved

Functional benefit

Products and services

• Stents and Stent Delivery Systems Medical device stents and associated stent delivery systems used by hospitals and healthcare systems to treat cardiovascular and peripheral vascular conditions through minimally invasive vascular interventions.
• Vascular Snares Vascular snares sold to hospitals and healthcare systems for use during minimally invasive vascular procedures, including peripheral vascular interventions.
• Catheter-based Vascular Devices Catheter-based medical devices for vascular procedures used by hospitals and healthcare systems, the subject of patent litigation with Teleflex reflecting proprietary catheter technology in this category.
• Neurovascular Stroke Treatment Devices Neurovascular devices used by hospitals and healthcare systems for stroke diagnosis and treatment, supporting improved access to timely stroke care.

Quantifiable outcome

• Estimated 12 million people affected by stroke globally each year; global stroke burden estimated at USD 900 billion annually

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Royal PhilipscoreStrategic or Co-development Partner · 24 October 2024Medtronic Neurovascular announced a strategic advocacy partnership with Royal Philips focused on raising awareness around stroke care and improving access to timely diagnosis and treatment. The collaboration focuses on three key areas: raising public awareness of stroke symptoms, expanding stroke-ready hospitals and professional training, and leveraging advanced imaging and digital health tools for integrated stroke care systems. Both companies joined the World Stroke Organization (WSO) Advocacy Coalition.

Recent moves3 records

Expansion highlights4 records

Direct peers

• Penumbra: Penumbra specializes in neurovascular thrombectomy and stroke care devices, directly comparable to Medtronic Vascular's neurovascular and stroke-treatment portfolio (including MindFrame-derived technologies).
• Teleflex: Teleflex manufactures vascular access catheters and interventional devices; recently involved in catheter patent litigation with Medtronic, making it a direct competitor in catheter technology.
• Boston Scientific: Major interventional cardiology and peripheral vascular competitor; directly overlaps with Medtronic Vascular in coronary stents, peripheral interventions, and catheter-based therapies, serving similar hospital customers.
• Edwards Lifesciences: Edwards focuses on structural heart and critical care; broader cardiovascular player with overlapping catheter and vascular intervention capabilities to Medtronic Vascular's cardiovascular device portfolio.
• Abbott Vascular: Abbott's cardiovascular division manufactures coronary stents, structural heart, and peripheral vascular devices; competes head-on with Medtronic Vascular in coronary and peripheral vascular intervention.
• Stryker Neurovascular: Stryker's Neurovascular division offers coil and flow-divertor technologies for stroke and aneurysm treatment, serving the same neurovascular hospital customers as Medtronic Neurovascular.
• Terumo (Terumo Interventional Systems): Terumo manufactures interventional catheters, guidewires, and vascular access devices; directly comparable to Medtronic Vascular's catheter and vascular access portfolio across cardiovascular procedures.

Regional players

• iVascular: European-headquartered peripheral vascular device manufacturer with comparable catheters and stent systems; competes in overlapping product categories but primarily in EMEA geographies.

Emerging players

• Merit Medical Systems: Merit Medical specializes in peripheral vascular intervention devices and accessories; smaller but growing peer with partial product overlap on catheters and embolic delivery to Medtronic Vascular.

Broad incumbents

• Johnson & Johnson (Cordis / Cerenovus): J&J's Cordis and Cerenovus franchises cover vascular access and neurovascular devices; broader incumbent with overlapping portfolio but not solely focused on vascular interventions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/medtronic-vascular

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medtronic Vascular